Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.

[1]  G. Comi,et al.  Congenital muscular dystrophies with defective glycosylation of dystroglycan , 2009, Neurology.

[2]  Masao Kobayashi,et al.  Different neuroradiological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type Ia , 2009, Brain and Development.

[3]  T. Hennet,et al.  On the nomenclature of congenital disorders of glycosylation (CDG) , 2008, Journal of Inherited Metabolic Disease.

[4]  Y. Maeda,et al.  Dolichol-phosphate mannose synthase: structure, function and regulation. , 2008, Biochimica et biophysica acta.

[5]  R. Hennekam,et al.  Peters Plus Syndrome Is a New Congenital Disorder of Glycosylation and Involves Defective O-Glycosylation of Thrombospondin Type 1 Repeats* , 2008, Journal of Biological Chemistry.

[6]  A. Kastaniotis,et al.  Human RFT1 deficiency leads to a disorder of N-linked glycosylation. , 2008, American journal of human genetics.

[7]  Susan C. Brown,et al.  Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. , 2007, Brain : a journal of neurology.

[8]  J. Denecke,et al.  A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. , 2007, American journal of human genetics.

[9]  K. Campbell,et al.  Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness , 2006, Annals of neurology.

[10]  W. Tanner,et al.  Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. , 2006, Angewandte Chemie.

[11]  R. Houlston,et al.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency , 2006, Nature Medicine.

[12]  R. Dwek,et al.  Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria. , 2006, Biochimica et biophysica acta.

[13]  Y. Maeda,et al.  DPM1, the Catalytic Subunit of Dolichol-phosphate Mannose Synthase, Is Tethered to and Stabilized on the Endoplasmic Reticulum Membrane by DPM3* , 2006, Journal of Biological Chemistry.

[14]  M. Aebi,et al.  Biosynthesis of Lipid-linked Oligosaccharides in Saccharomyces cerevisiae , 2005, Journal of Biological Chemistry.

[15]  C. Sato,et al.  Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins. , 2005, The American journal of pathology.

[16]  J. Bourke,et al.  Cardiac and respiratory failure in limb‐girdle muscular dystrophy 2I , 2004, Annals of neurology.

[17]  H. Brunner,et al.  Glyc‐O‐genetics of Walker–Warburg syndrome , 2004, Clinical genetics.

[18]  T. Hennet,et al.  Congenital disorder of glycosylation (CDG) type Ie. A new patient , 2004, Journal of Inherited Metabolic Disease.

[19]  O. Bohorov,et al.  Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.

[20]  K. von Figura,et al.  Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. , 2004, American journal of human genetics.

[21]  R. U. Margolis,et al.  Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Contreras,et al.  Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I. , 2003, Glycobiology.

[23]  G. Hülskamp,et al.  Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia , 2002, European Journal of Pediatrics.

[24]  G. Hoffmann,et al.  Congenital Disorder of Glycosylation IId (CDG-IId) - A New Entity: Clinical Presentation with Dandy-Walker Malformation and Myopathy , 2002, Neuropediatrics.

[25]  Susan C. Brown,et al.  Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. , 2001, Human molecular genetics.

[26]  H. Freeze,et al.  A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). , 2001, The Journal of clinical investigation.

[27]  G. Raymond,et al.  MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. , 2001, The Journal of clinical investigation.

[28]  M. Hoylaerts,et al.  Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications , 2001, Journal of Inherited Metabolic Disease.

[29]  J. Hofsteenge,et al.  Requirement of the Lec35 gene for all known classes of monosaccharide-P-dolichol-dependent glycosyltransferase reactions in mammals. , 2001, Molecular biology of the cell.

[30]  K. Kangawa,et al.  Initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG‐P and is regulated by DPM2 , 2000, The EMBO journal.

[31]  E. Berger,et al.  Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. , 2000, The Journal of clinical investigation.

[32]  H. Freeze,et al.  Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) , 2000, The Journal of clinical investigation.

[33]  U. Stephani,et al.  Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl‐P‐Man:Man5 GlcNAc2‐PP‐dolichyl mannosyltransferase , 1999, The EMBO journal.

[34]  M. Aebi,et al.  The dolichol pathway of N-linked glycosylation. , 1999, Biochimica et biophysica acta.

[35]  R. Watanabe,et al.  DPM2 regulates biosynthesis of dolichol phosphate‐mannose in mammalian cells: correct subcellular localization and stabilization of DPM1, and binding of dolichol phosphate , 1998, The EMBO journal.

[36]  Y. Maeda,et al.  A Homologue of Saccharomyces cerevisiae Dpm1p Is Not Sufficient for Synthesis of Dolichol-Phosphate-Mannose in Mammalian Cells* , 1998, The Journal of Biological Chemistry.

[37]  J. Hofsteenge,et al.  Protein C-mannosylation is enzyme-catalysed and uses dolichyl-phosphate-mannose as a precursor. , 1998, Molecular biology of the cell.

[38]  F. Hanefeld,et al.  NormalN-oligosaccharyltransferase activity in fibroblasts from patients with carbohydrate-deficient glycoprotein syndrome , 1994, Journal of Inherited Metabolic Disease.

[39]  E. Yeh,et al.  Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the Thy-1 expression mutants. , 1991, The Journal of biological chemistry.

[40]  R. Schwarz,et al.  Biosynthesis of glycosyl‐phosphatidylinositol lipids in Trypanosoma brucei: involvement of mannosyl‐phosphoryldolichol as the mannose donor. , 1990, The EMBO journal.

[41]  E. L. Kean.  Stimulation by dolichol phosphate-mannose and phospholipids of the biosynthesis of N-acetylglucosaminylpyrophosphoryl dolichol. , 1985, The Journal of biological chemistry.

[42]  L. Lehle.  Biosynthesis of the core region of yeast mannoproteins. Formation of a glucosylated dolichol-bound oligosaccharide precursor, its transfer to protein and subsequent modification. , 1980, European journal of biochemistry.

[43]  Mark Sutton-Smith,et al.  Glycomic profiling of cells and tissues by mass spectrometry: fingerprinting and sequencing methodologies. , 2006, Methods in enzymology.

[44]  村上 てるみ.  Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness , 2006 .

[45]  H. G. van Eijk,et al.  Optimized separation and quantitation of serum and cerebrospinal fluid transferrin subfractions defined by differences in iron saturation or glycan composition. , 1994, Advances in experimental medicine and biology.